Successful Treatment of Severe Tuberculosis With Contezolid Add‐On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report
Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against <i>Mycobacterium tuberculosis</i>. Contezolid add-on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.
Authors
- Jixue Zhou (ORCID: https://orcid.org/0000-0003-3819-0287)
- Liuqing Zhou
- Yimin Wang (ORCID: https://orcid.org/0000-0003-0191-240X)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/ccr3.70001
- Citations
- 2
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.78